v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating Activities    
Net loss $ (17,826,209) $ (17,200,488)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 574,229 752,882
Amortization of operating lease right-of-use assets 221,893 182,954
(Gain) loss on disposal of fixed assets (2,361) 330
Amortization of debt discount 1,179,682 1,054,935
Stock-based compensation 649,933 1,872,586
Loss on extinguishment of debt 1,823,635 0
(Gain) loss on change in warrant liability (20,978) 14,884
Loss (gain) on change in fair value of derivative liability 1,078,858 (723,124)
Mandatory default amount on convertible notes payable 623,333 0
Changes in operating assets and liabilities:    
Prepaid expenses 83,981 (121,410)
Accounts receivable 135,179 (198,511)
Other current assets (112,788) (20,370)
Deferred revenue, current and non-current (2,353,798) (512,631)
Accounts payable and accrued liabilities (855,676) 804,192
Management and directors' fees payable 6,278 85,736
Right-of-use assets operating leases liabilities (230,727) (183,432)
Net Cash Used In Operating Activities (15,025,536) (14,191,467)
Investing Activities    
Purchases of property and equipment (57,942) (78,591)
Net Cash Used In Investing Activities (57,942) (78,591)
Financing Activities    
Net proceeds from issuances of common shares 15,749,399 4,454,633
Tax withholdings paid related to stock-based compensation (15,831) (159,849)
Proceeds from grants repayable 0 32,426
Net proceeds from issuances of convertible note and warrants 1,755,000 5,774,202
Proceeds from long-term debt 962,723 1,570,176
Payments on long-term debt (723,213) (697,174)
Payments on grants repayable (87,574) 0
Payments on convertible loan note (651,667) 0
Payments on finance lease obligations (53,706) (37,361)
Net Cash Provided By Financing Activities 16,935,131 10,937,053
Effect of foreign exchange on cash (611,614) 267,983
Net change in cash and cash equivalents 1,240,039 (3,065,022)
Cash and cash equivalents - Beginning of the Period 1,117,028 3,264,429
Cash and cash equivalents - End of the Period 2,357,067 199,407
Supplemental Disclosures of Cash Flow Information    
Interest paid 385,713 363,825
Non-Cash Financing Activities    
Deemed dividend - down round provision in warrants 563,300 0
Common stock issued upon settlement of vested RSUs 70 1,654
Fair value of derivative liability recognized upon issuance of convertible note 385,300 1,042,471
Issuance of warrants in connection with convertible note offering 615,852 1,983,842
Debt issuance costs recognized upon issuance of convertible note 645,000 1,740,825
Common stock issued for settlement of convertible note repayments 8,677,800 0
Offering costs from issuance of common stock 328,693 0
Non-cash note payable $ 262,552 $ 292,470

Source